Imunon creates proprietary immunology and DNA-based technology for difficult-to-treat conditions
Our innovative DNA platforms instruct the body’s immune system to create potent responses when and where they’re needed.
Today, we’re focusing our TheraPlas® platform on ovarian cancer and validating our PlaCCine platform via the SARS-CoV-2 virus, and we envision a future where these technologies fight a range of cancers and infectious diseases.
We are scientists, researchers, and innovators who believe in the power of immunology and DNA as the building block for health and well-being, and we’re just getting started.
View the recent launch of our new cGMP Factory facility, based in Huntsville, Alabama
Next Generation Leadership
Imunon is led by an experienced, innovative, and capital-savvy management team with a track record of bringing products to market at global brands like Amgen, Moderna, Roche, Valentis, Novavax, and more.
We value partnership, collaboration, and the power of science to create something bigger than ourselves.
Imunon is developing new medicines that harness the building blocks of life to work in harmony with the body’s immune system.
We Value Evidence And Innovation Over Opinion
We Are Open, Genuine And Ethical
We Are Bold And Determined To Take On Challenges
We Seek First To Understand With Honesty And Transparency
We Value The Power Of Working Together
We Pivot When Needed And We Are Decisive And Action Oriented
Passion Led Us Here
We are a team of dedicated scientists and innovators working together to overcome barriers and advance scientific discoveries. We’re in this together, and we understand that achieving our mission means a commitment to constant improvement in everything we do.
combined years of leadership experience in the biotech industry
key partners, including the world’s most respected research institutions
products in the pipeline with an addressable market worth $15B+
There are no open positions at this time.